Sit Investment Associates Inc Corcept Therapeutics Inc Transaction History

Sit Investment Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$10.03 - $15.71 $786,853 - $1.23 Million	-78,450 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$12.27 - $15.65 $211,044 - $269,180	-17,200 Reduced 17.98%	78,450 $1.1 Million
Q4 2017 Jan 10, 2018	BUY	$15.77 - $20.72 $555,892 - $730,380	35,250 Added 58.36%	95,650 $1.73 Million
Q3 2017 Oct 18, 2017	BUY	$12.3 - $19.3 $742,920 - $1.17 Million	60,400	60,400 $1.17 Million

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.39B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Sit Investment Associates Inc with notifications on news.